News - Neurological, Dr Reddy's Laboratories


Popular Filters

Indian drugmakers set to capitalize on Cymbalta generics


Approval for the generic version of Eli Lilly’s Cymbalta duloxetine by the US health regulator (The…

Asia-PacificAurobindo PharmaCymbaltaDr Reddy's LaboratoriesDuloxetine HclEli LillyGenericsHealthcareIndiaLupinMarkets & MarketingNeurologicalPatentsSun Pharmaceutical IndustriesTorrent Pharmaceuticals

US FDA approves first generic versions of antidepressant drug Cymbalta

US FDA approves first generic versions of antidepressant drug Cymbalta


The US Food and Drug Administration yesterday approved the first generic versions of drug major Eli Lilly’s…

Aurobindo PharmaCymbaltaDr Reddy's LaboratoriesDuloxetine HclEli LillyGenericsLupinNeurologicalNorth AmericaRegulationSun Pharmaceutical IndustriesTeva Pharmaceutical Industries

Generic launches by Mylan, Stada Arz and Dr Reddy's


US copy drugs maker Mylan (NYSE: MYL) has launched norethindrone tablets USP, 0.35 the generic version…

Dr Reddy's LaboratoriesEuropeGenericsLamictal XRMarkets & MarketingMen's HealthMicronorMylan LaboratoriesNeurologicalNorth AmericaReproductiveSTADA ArzneimittelViagra

Lundbeck infringement action against escitalopram generics in Spain is dismissed


In a judgment issued last month, Spain’s Barcelona Commercial Court Number 4 rejected the infringement…

CipralexDr Reddy's LaboratoriesEscitalopram OxalateEuropeGenericsLegalLundbeckNeurologicalPatentsPharmaceutical

Back to top